Back to Gastroenterology
Gastroenterologyv2003Evidence-Based

Apri For Hepatitis C Cirrhosis Probability

APRI: AST-to-platelet ratio index for liver fibrosis in hepatitis C.

Clinical Input Parameters

U/L
Range: 1 — 5000 U/L
U/L
Range: 10 — 100 U/L
x10^3/uL
Range: 10 — 1000 x10^3/uL
Clinical Assessment
Awaiting Parameters
apri
—index
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Apri For Hepatitis C Cirrhosis Probability is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within gastroenterology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

APRI = (AST/ULN) / platelets(x10^9/L) x 100

Clinical Pearls & Practice Notes

  • Validated primarily in chronic hepatitis C.

Evidence & Literature Citations

  1. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518-526.

Score Interpretation Ranges

Cirrhosis likely2 – pts

Cirrhosis likely

Significant fibrosis1 – pts

Significant fibrosis possible

Low0 – pts

Significant fibrosis unlikely

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.